Navigation Links
Clinical Ink’s Jonathan Andrus Invited to Speak at the Duke-Margolis Center for Health Policy Public Meeting
Date:6/13/2019

Clinical Ink, a global clinical trial technology company that is transforming the clinical trial experience, is pleased to announce that Jonathan Andrus, chief business officer at Clinical Ink, has been invited to be a panelist in a public meeting hosted by the Duke-Margolis Center for Health Policy on July 1, 2019, in Washington, D.C. The workshop, convened under a cooperative agreement with the FDA, will discuss opportunities to improve the implementation of risk-based monitoring (RBM) in clinical investigations.

Andrus will participate as a key expert alongside Ann Meeker-O’Connell of IQVIA and Mike Henderson of SAS for the session, “Analytical Tools and Methods to Support Risk-Based Monitoring.” The panelists will explore available analytic approaches, technology, and tools that could support the implementation of RBM.

“Understanding why RBM approaches have not been widely adopted and what can be done to encourage their use will benefit the entire global pharma and biotech industry,” said Andrus. “I’m honored to have been selected to participate in this discussion.”

RBM allows sponsors to concentrate their oversight on the most critical, highest risk data elements, procedures, and processes necessary to achieve the objectives of their clinical investigations. This workshop brings together thought leaders from the FDA, EMA, ACRO, BIO, TransCelerate, and more to discuss the challenges, barriers, and enablers that influence the adoption of RBM and opportunities to improve its implementation.

Register to participate in person or via webcast. Visit Clinical Ink for more information on RBM and its pioneering eSource clinical technology platform, eCOA, and ePRO solutions.

About Clinical Ink
Clinical Ink is a global clinical trial technology company that is transforming the clinical trial experience. Founded in 2007, the company’s proven and future-built eSource platform, which includes solutions for EDC replacement, eCOA, ePRO, and more, accelerates time to value while delivering scientific results that matter. With offices in Winston-Salem, NC, and Philadelphia, PA, Clinical Ink is advancing the business model responsible for bringing new treatments to market. Visit clinicalink.com.

Read the full story at https://www.prweb.com/releases/clinical_inks_jonathan_andrus_invited_to_speak_at_the_duke_margolis_center_for_health_policy_public_meeting/prweb16376200.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. Kidney Week 2013: New innovations in clinical science
2. Salar Joins Medical Informatics Experts to Judge AMIA’s First Ever Student Design Challenge: Reinventing Clinical Documentation
3. The DelRay Recovery Center Appoints Britt Bonner as the Director of Clinical Outreach
4. Clinical trial looks at impact of platelet-rich plasma therapy on tennis elbow
5. Nemours receives Dept. of Defense award to study physicians maintenance of optimal clinical program
6. Clinical trial finds concurrent therapy not necessary to achieve high pathological in breast cancer
7. Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business
8. Italian study examines clinical predictors of acute urinary symptoms after radiotherapy for prostate
9. Idol Lash: The Clinically Proven Eyelash Growth Enhancer Now Available in the Market With 1 Extra Bottle Offer
10. Paid Asthma Clinical Trial Now Enrolling at Achieve Clinical Research Near Birmingham, Alabama; Accepting M/F Patients with Asthma Age 12 - 75
11. Tinnitus Global Clinical Trials Review, H2, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/12/2019)... ... August 12, 2019 , ... Israeli ... finding significant therapeutic benefits in the use of floristry as treatment for fibromyalgia. ... included a total of 61 female fibromyalgia patients participating in a 12-week floral ...
(Date:8/9/2019)... ... August 09, 2019 , ... ... of its global expansion into Europe’s third largest pharmaceutical market with the recent ... Clinical’s entrance into Italy now completes the organization’s thorough coverage of Western Europe. ...
(Date:8/9/2019)... (PRWEB) , ... August 09, 2019 , ... ... Centers Lebanon, its second opioid treatment program (OTP) in Ohio. MedMark Lebanon will ... opioid addiction. The clinic, located at 1521 Walmart Drive, is now accepting patients. ...
(Date:8/9/2019)... ... 08, 2019 , ... Guruji Mahendra Trivedi is an innovative ... practical and spiritual levels. , Founder of the Trivedi Effect®, Guruji Mahendra ... their understanding, as well as, to illuminate the path of awareness and higher ...
(Date:8/8/2019)... ... August 08, 2019 , ... Makers ... Customer Sales and Service World Awards® for its dedication to customers satisfaction and ... from a broad spectrum of industry voices, encompasses the world’s best in Sales ...
Breaking Medicine News(10 mins):
(Date:8/14/2019)... ... August 13, 2019 , ... ... and age together through the power of play, is proud to announce its ... 2019 Caregiver Friendly® Awards. Today’s Caregiver, the first national magazine for all family ...
(Date:8/12/2019)... ... August 12, 2019 , ... Dr. Kenrick ... chief authority in the field of cosmetic plastic and reconstructive surgery, Dr. Spence ... Dr. Spence for his knowledge and expertise in treating keloid scars . ...
(Date:8/12/2019)... ... ... Innovators and startup companies with devices designed to improve neonatal or NICU care now ... “Make Your Medical Device Pitch for Kids!” competition funded by the National Capital ... in Boston, Mass. in conjunction with the 7th Annual Pediatric Device Innovation Symposium ...
Breaking Medicine Technology: